secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001140361-25-016338
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director R. Keith Woods not standing for re-election to Rocket board
--------------------------------------------------------------------

- R. Keith Woods informed board he accepted COO role at another biopharma company; will not stand for re-election at 2025 annual meeting.
- His term as director and membership on audit and commercial committees ends at the 2025 annual meeting.
- Departure is not due to any disagreement with Rocket's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125016338/0001140361-25-016338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125016338/ef20048161_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-016338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer